StonvexLoading…
StonvexCore line items from ES's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.49B | $11.80B | $11.89B | $12.27B |
Operating Income | $2.99B | $2.41B | $2.40B | $2.20B |
Net Income | $1.70B | $819.17M | $-434.70M | $1.41B |
EPS (Diluted) | $4.56 | $2.27 | $-1.26 | $4.05 |
Total Assets | $63.79B | $59.59B | $55.61B | $53.23B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $135.40M | $26.70M | $53.90M | $374.60M |
Free Cash Flow OCF − CapEx | $-45.10M | $-2.32B | $-2.69B | $-1.04B |
Shares Outstanding | 375.42M | 366.61M | 349.54M | 348.44M |